Ryoji Yoshii

Title: Ryoji Yoshii: Innovator in Pharmaceutical Coatings

Introduction

Ryoji Yoshii is a prominent inventor based in Mishima, Japan. He has made significant contributions to the field of pharmaceutical preparations, holding a total of seven patents. His work focuses on developing innovative coating agents that enhance the properties of pharmaceutical solid preparations.

Latest Patents

Yoshii's latest patents include a coating agent for pharmaceutical solid preparation, a film coating agent for solid preparation, and a solid preparation using the same. The coating agent for a pharmaceutical solid preparation is designed to impart excellent barrier properties equivalent to those of a PTP sheet without affecting the disintegration properties of the pharmaceutical solid preparation. This agent includes a polyethylene glycol with an average molecular weight ranging from 950 to 25,000 and a swelling clay, with a mass ratio of polyethylene glycol to swelling clay between 2:8 to 6:4. The film coating agent for solid formulation consists of a water-soluble cellulose derivative, swelling clay, a cationic surfactant, and a fatty acid. The mass ratio of swelling clay to water-soluble cellulose derivative is maintained between 2:8 to 8:2, and the content of the cationic surfactant is specified to be not less than 0.5 equivalents and not more than 3.0 equivalents relative to a cation exchange equivalent of the swelling clay.

Career Highlights

Ryoji Yoshii is currently associated with Toray Industries, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the technology behind pharmaceutical coatings, making significant impacts on the industry.

Collaborations

Yoshii collaborates with talented individuals such as Yuki Fujisaki and Yuki Hayashi, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ryoji Yoshii's contributions to pharmaceutical coatings exemplify the importance of innovation in enhancing drug delivery systems. His patents reflect a commitment to improving the efficacy and safety of pharmaceutical preparations.